Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sawai Narrowly Misses Annual Sales Forecast For 2023

Industry Analysts Remain Cautiously Optimistic Over 2024 Guidance

May 21 2024

• By Adam Zamecnik

Japanese Yen money — • Source: Shutterstock

Related Content

Sawai Sets Out US Recalibration

Dec 08 2020

Sawai Reports Slight Growth In Japan Amid Challenges

Feb 27 2024

Sawai’s Upsher-Smith Gets New Leadership Amid ‘Drastic Restructuring’

May 13 2022

Bora Completes Upsher-Smith Takeover

Apr 02 2024

A Year's Struggle: How Japan Is Recovering Damaged Generic Supplies After Quality Violations

Apr 12 2022

Additional Topics

Japan Asia Pacific Generic Drugs Sales & Earnings Strategy BioPharmaceutical

More from Generics

More from Products

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.